반응 #73197

ord-22f39867eb7f48ba933a7b09c0f14b98

용매

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    workup.STIRRINGthis was stirred for 3 hours
  2. 2
    기타The majority of solvent was removed in vacuo
  3. 3
    기타the crude residue was purified by preparative-HPLC (
  4. 4
    세척C18 eluting with a gradient of ACN/H2O containing 0.1% TFA)
  5. 5
    기타followed by re-purification via preparative-HPLC (
  6. 6
    세척C18 eluting with a gradient of ACN/H2O containing 0.15% NH4OH)

실험 절차

A mixture of 2-methyl-2-[4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-pyrazol-1-yl]propanoic acid (23 mg, 0.000085 mol) and N,N-carbonyldiimidazole (CDI) (21 mg, 0.00013 mol) in 2 mL of DMF was stirred for 3 hours. An excess of solid NH4Cl and TEA was added to the mixture and this was stirred for 3 hours. The majority of solvent was removed in vacuo, and the crude residue was purified by preparative-HPLC (C18 eluting with a gradient of ACN/H2O containing 0.1% TFA) followed by re-purification via preparative-HPLC (C18 eluting with a gradient of ACN/H2O containing 0.15% NH4OH) to afford 2-methyl-2-[4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-pyrazol-1-yl]propanamide (6 mg, 26%). 1H NMR (400 MHz, d6-DMSO): 11.63 (s, 1H), 8.44 (s, 1H), 8.16 (s, 1H), 8.14 (s, 1H), 7.47 (t, 1H), 7.29 (d, 1H), 7.21 (s, 1H), 6.93 (s, 1H), 6.80 (dd, 1H), 1.77 (s, 6H); MS(ES): 270 (M+1).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08541425B2uspto-grants-2013_09